2m 2m 2m 2m 2m 2m 2m
SERINA THERAP (SER)
NYSE
$2.17+$0.12 (+6.05%)
Price as of Jul 14, 2026 8:33 AM EDT- $30.7MMarket Cap
- -60.20%1-Year Change
- BiotechnologyIndustry
SERINA THERAP (SER)
$2.17+$0.12 (+6.05%)
SER | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.05 | ||
Change | -$0.09 (-4.21%) | ||
Open | $2.08 | ||
High | $2.14 | ||
Low | $2.04 | ||
Previous Close | $2.14 | ||
Volume | 37,680 | ||
30-Day Average Volume | 72,225 | ||
1-Week Change | 5.13% | ||
1-Month Change | 11.41% | ||
1-Year Change | -60.20% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 15.0M | ||
Total Assets | $27.3M | ||
Market Cap | $30.7M | ||
Enterprise Value | $9.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.9M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$6.9M | ||
EBITDA | -$6.9M | ||
Net Working Capital | $20.1M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue